Gastric cancer

A recently published study has found a link between long-term use of proton pump inhibitors (PPIs) and an increased risk of developing gastric cancer (GC). Read more


Oraxol is an oral form of the approved drug paclitaxel, with HM30181, a highly potent and selective, P-glycoprotein inhibitor of the gastro-intestinal tract. Read more